2ETF | A:1-437; B:1-437 | CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN |
2G7K | A:1-416; B:1-416 | STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN, SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS |
2G7N | A:1-419 | STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS |
2G7P | B:1-417; A:1-417 | STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS |
2G7Q | B:1-417; A:1-417 | STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS |
2QN0 | A:2-430 | STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 LIGHT CHAIN PROTEASE |
3DEB | A:-2-430 | CRYSTAL STRUCTURE OF APO FORM (ZINC REMOVED) OF THE BOTULINUM NEUROTOXIN TYPE C LIGHT CHAIN |
3FIE | A:2-416; B:2-412 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH1) |
3FII | A:2-412 | CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH2) |